Serum Concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are Associated with Increased 3-Month Mortality in Acute Heart Failure Patients.

MLA

Stryeck, Sarah, et al. “Serum Concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate Are Associated with Increased 3-Month Mortality in Acute Heart Failure Patients.” Scientific Reports, vol. 9, no. 1, May 2019, p. 6743. EBSCOhost, https://doi.org/10.1038/s41598-019-42937-w.

APA

Stryeck, S., Gastrager, M., Degoricija, V., Trbušić, M., Potočnjak, I., Radulović, B., Pregartner, G., Berghold, A., Madl, T., & Frank, S. (2019). Serum Concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are Associated with Increased 3-Month Mortality in Acute Heart Failure Patients. Scientific Reports, 9(1), 6743. https://doi.org/10.1038/s41598-019-42937-w

Chicago

Stryeck, Sarah, Michaela Gastrager, Vesna Degoricija, Matias Trbušić, Ines Potočnjak, Bojana Radulović, Gudrun Pregartner, Andrea Berghold, Tobias Madl, and Saša Frank. 2019. “Serum Concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate Are Associated with Increased 3-Month Mortality in Acute Heart Failure Patients.” Scientific Reports 9 (1): 6743. doi:10.1038/s41598-019-42937-w.